Cardiovascular disease in Type 1 melitus: Young adults to adolescents

1 型糖尿病中的心血管疾病:年轻人到青少年

基本信息

  • 批准号:
    7406752
  • 负责人:
  • 金额:
    $ 13.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-01 至 2012-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Type 1 Diabetes Mellitus (T1D) affects 1.4 million people in the U.S. and its incidence is increasing by 3- 5% annually. While numerous promising therapeutic modalities are being investigated, currently no cure exists and the patients succumb prematurely to long-term complications, especially coronary artery disease (CAD). Excess risk of CAD seen in T1D is not fully explained by traditional risk factors identified in non-DM individuals and those with type 2 diabetes. Hyperglycemia, hypertension, dyslipidemia, albuminuria, obesity, inflammation, and low adiponectin levels clearly play a role. Insulin resistance may be the primary problem, underlying the above risk factors, but is more difficult to quantify in T1D subjects. In this application, I am proposing a series of studies with the overarching dual goal of acquiring advanced research skills while translating findings and methods of investigation of the pathogenesis of CAD in T1D adults to diabetic children -the ultimate target population for primary prevention. The goal of this training grant is to pursue the following specific aims to develop research skills within the framework of the Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study to test hypotheses specific to this application: 1) to disentangle the inter-relationship between hyperglycemia, kidney function, hypertension, and insulin resistance (defined by visceral obesity, low adiponectin levels and dyslipidemia) in the development of premature CAD using the baseline and follow-up data from the CACTI cohort; 2) To perform euglycemic hyperinsulinemic clamp studies in young adults in CACTI to develop an accurate estimate of insulin sensitivity based on easy to measure traditional and novel markers in T1D subjects; and 3) To establish a cohort of 120 adolescents (ages 12-19) with T1D (n=60) and non-DM (n=60). Formation and analysis of cardiovascular risk factors in this cohort at the Barbara Davis Center for Childhood Diabetes will provide pilot data for a future R01 application. These goals have been identified to translate research on CVD in T1D from young adults to adolescents. Although guidelines for CVD risk factors in adults are established, screening and intervention in adolescents with T1D are either absent or based on extrapolation from adult data. The general hypothesis for this research is that greatly elevated CVD risk factors are present in youth with T1D and screening and treatment thresholds need to be determined.
描述(由申请人提供): 1型糖尿病(T1D)在美国影响140万人,其发病率每年增加3-5%。尽管正在研究许多有前途的治疗方式,但目前尚无治愈方法,患者过早地屈服于长期并发症,尤其是冠状动脉疾病(CAD)。在非DM个体和2型糖尿病患者中发现的传统危险因素并未完全解释T1D中观察到的CAD的过多风险。高血糖,高血压,血脂异常,蛋白尿,肥胖,炎症和低脂联素水平显然起作用。胰岛素抵抗可能是上述危险因素的主要问题,但在T1D受试者中更难量化。在此应用中,我提出了一系列研究,其总体双重目标是获得高级研究技能,同时将T1D成人CAD发病机理的发现和调查方法转化为糖尿病儿童,这是初级预防的最终目标人群。这项培训赠款的目标是追求以下特定旨在在1型糖尿病(CACTI)研究中发展冠状动脉钙化框架内的研究技能(CACTI)研究,以测试该应用特定的假设:1)散布相互关联的相互关系,使高血糖,肾脏功能,高血压和胰岛素的抑制作用(肾小管降低)的依据(肾脏均应降低)(抑制性征症)(使用基线和仙人掌队列的后续数据开发过早CAD; 2)在仙人掌中的年轻人中进行电子高糖性高胰岛素夹具研究,以基于易于衡量T1D受试者的传统和新颖标记的胰岛素敏感性的准确估计; 3)建立与T1D(n = 60)和非DM(n = 60)的120名青少年(12-19岁)组成的队列。在芭芭拉·戴维斯(Barbara Davis)儿童糖尿病中心,该队列中心血管危险因素的形成和分析将为未来的R01应用提供试验数据。已经确定了这些目标是将T1D中CVD的研究从年轻人转化为青少年。尽管建立了成人CVD危险因素的指南,但对T1D的青少年进行筛查和干预是不存在的,要么是基于从成人数据中推断出来的。这项研究的总体假设是,在具有T1D的青年和筛查和治疗阈值中,CVD危险因素大大升高。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Matthew Maahs其他文献

David Matthew Maahs的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Matthew Maahs', 18)}}的其他基金

Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Study
新诊断儿童 T1D 的团队合作、目标、技术和严格控制:4T 研究
  • 批准号:
    10337046
  • 财政年份:
    2020
  • 资助金额:
    $ 13.34万
  • 项目类别:
A Clinical Study of Latiglutenase as a Treatment for Type 1 Diabetics with Celiac Disease
Latiglutenase 治疗 1 型糖尿病合并乳糜泻的临床研究
  • 批准号:
    10216393
  • 财政年份:
    2020
  • 资助金额:
    $ 13.34万
  • 项目类别:
Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Study
新诊断儿童 T1D 的团队合作、目标、技术和严格控制:4T 研究
  • 批准号:
    10581678
  • 财政年份:
    2020
  • 资助金额:
    $ 13.34万
  • 项目类别:
A Clinical Study of Latiglutenase as a Treatment for Type 1 Diabetics with Celiac Disease
Latiglutenase 治疗 1 型糖尿病合并乳糜泻的临床研究
  • 批准号:
    10255820
  • 财政年份:
    2020
  • 资助金额:
    $ 13.34万
  • 项目类别:
Training Research Leaders in Type 1 Diabetes
培训 1 型糖尿病研究领导者
  • 批准号:
    10450885
  • 财政年份:
    2019
  • 资助金额:
    $ 13.34万
  • 项目类别:
Training Research Leaders in Type 1 Diabetes
培训 1 型糖尿病研究领导者
  • 批准号:
    10655524
  • 财政年份:
    2019
  • 资助金额:
    $ 13.34万
  • 项目类别:
Training Research Leaders in Type 1 Diabetes
培训 1 型糖尿病研究领导者
  • 批准号:
    10205060
  • 财政年份:
    2019
  • 资助金额:
    $ 13.34万
  • 项目类别:
Accelerating Solutions to Optimize Glycemic Control and Weight Management In Young Adults with Type 1 Diabetes
加速优化 1 型糖尿病年轻成人血糖控制和体重管理的解决方案
  • 批准号:
    9302074
  • 财政年份:
    2017
  • 资助金额:
    $ 13.34万
  • 项目类别:
FL3X: An Adaptive Intervention to Improve Outcomes for Youth with Type 1 Diabetes
FL3X:改善 1 型糖尿病青少年预后的适应性干预措施
  • 批准号:
    8644984
  • 财政年份:
    2013
  • 资助金额:
    $ 13.34万
  • 项目类别:
Cardiovascular disease in Type 1 melitus: Young adults to adolescents
1 型糖尿病中的心血管疾病:年轻人到青少年
  • 批准号:
    7647063
  • 财政年份:
    2007
  • 资助金额:
    $ 13.34万
  • 项目类别:

相似国自然基金

儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
  • 批准号:
    32371121
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
  • 批准号:
    32200888
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
  • 批准号:
    82173590
  • 批准年份:
    2021
  • 资助金额:
    56.00 万元
  • 项目类别:
    面上项目

相似海外基金

Parent-adolescent informant discrepancies: Predicting suicide risk and treatment outcomes
父母与青少年信息差异:预测自杀风险和治疗结果
  • 批准号:
    10751263
  • 财政年份:
    2024
  • 资助金额:
    $ 13.34万
  • 项目类别:
Maternal immune activation remodeling of offspring glycosaminoglycan sulfation patterns during neurodevelopment
神经发育过程中后代糖胺聚糖硫酸化模式的母体免疫激活重塑
  • 批准号:
    10508305
  • 财政年份:
    2023
  • 资助金额:
    $ 13.34万
  • 项目类别:
Is gestational sleep apnea a previously unrecognized cause of maternal immune activation that predisposes male offspring to disease-relevant neural dysfunction?
妊娠期睡眠呼吸暂停是否是一种以前未被认识到的母体免疫激活的原因,导致男性后代容易出现与疾病相关的神经功能障碍?
  • 批准号:
    10680972
  • 财政年份:
    2023
  • 资助金额:
    $ 13.34万
  • 项目类别:
Imaging transcriptomics across developmental stages of early psychotic illness
早期精神病发展阶段的转录组学成像
  • 批准号:
    10664783
  • 财政年份:
    2023
  • 资助金额:
    $ 13.34万
  • 项目类别:
Expanding minority youth access to evidence-based care: A pilot effectiveness trial of a digital mental health intervention
扩大少数族裔青年获得循证护理的机会:数字心理健康干预措施的试点有效性试验
  • 批准号:
    10647287
  • 财政年份:
    2023
  • 资助金额:
    $ 13.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了